Home6978 • HKG
add
Immunotech Biopharm Ltd
Previous close
$3.95
Year range
$1.50 - $6.15
Market cap
2.03B HKD
Avg Volume
721.90K
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 42.92M | -34.76% |
Net income | -47.20M | 56.44% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -29.86M | 43.39% |
Effective tax rate | -0.99% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 57.49M | -67.51% |
Total assets | 564.04M | -33.35% |
Total liabilities | 580.50M | -14.05% |
Total equity | -16.45M | — |
Shares outstanding | 514.58M | — |
Price to book | -131.67 | — |
Return on assets | -19.02% | — |
Return on capital | -107.28% | — |
Cash Flow
Net change in cash
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -47.20M | 56.44% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2006
Website
Employees
154
